Press Release: Dupixent® (dupilumab) recommended for EU approval by the CHMP for the treatment of eosinophilic esophagitisGlobeNewsWire • 12/16/22
Press Release: Dupixent® (dupilumab) approved by European Commission as the first and only targeted medicine indicated for prurigo nodularisGlobeNewsWire • 12/15/22
Why Small Biotech Kymera Just Snagged Sanofi's Interest And Surged 28%Investors Business Daily • 12/14/22
Sanofi Says it does not intend to make an offer for horizon, leaving Amgen as sole bidderReuters • 12/11/22
SNY Stock Alert: Why 1 Analyst Says Zantac Ruling Is ‘Best-Case Scenario' for DrugmakersInvestorPlace • 12/07/22
GSK and Sanofi shares surge after Florida ruling dismisses Zantac lawsuits in what one analyst describes as ‘best-case scenario'Market Watch • 12/07/22
Why GSK Plc And Sanofi SA Stock Are Shooting Higher - GSK (NYSE:GSK), Sanofi (NASDAQ:SNY)Benzinga • 12/06/22
Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, SanofiInvestors Business Daily • 12/05/22
Press Release: Statement from Sanofi regarding: rule 2.12 of the takeover rulesGlobeNewsWire • 12/02/22
Press Release: Acoziborole: Investigational single-dose oral treatment raises hope for elimination of sleeping sickness in AfricaGlobeNewsWire • 11/30/22
Horizon Therapeutics Rockets As It Considers Potential Bids From Amgen, J&J, SanofiInvestors Business Daily • 11/29/22
Press Release: European Commission approves Enjaymo® (sutimlimab) for treatment of hemolytic anemia in adult patients with cold agglutinin diseaseGlobeNewsWire • 11/17/22
Top 5 stories of the week: Meta layoffs, Sanofi's billion-dollar deal and Snowflake updatesVentureBeat • 11/12/22